Genome Insight is a developer of a genome sequence (WGS) analysis and interpretation platform.
Genome Insight has raised $23.0M in total funding. The most recent round was Series B. The last funding was announced in November 2023.
Genome Insight's investors include InterVest Co., DSC Investment, Schmidt, Samsung Venture Investment, Ministry of SMEs and Startups.
Genome Insight is headquartered in La Jolla, United States.
Genome Insight is a developer of a genome sequence (WGS) analysis and interpretation platform.
Genome Insight is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genome Insight — Funding & Investors." VCBacked, November 1, 2023, https://www.vcbacked.co/company/genome-insight. Accessed October 30, 2026.
VCBacked. (2023). Genome Insight — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/genome-insight
{{cite web |title=Genome Insight — Funding & Investors |url=https://www.vcbacked.co/company/genome-insight |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated